Market_Media_Hub

  According to the latest report by the team of Market Research Future (MRFR), the global hemorrhoids treatment market is expected to grow at a decent rate of 7.1% during the forecast period of 2018 to 2023. The market growth is influenced by numerous factors like the increasing prevalence of lifestyle-based diseases, growing demand for treatment, an increasing demand for reducing infections & complications relating to hemorrhoids, and an increasing number of surgeries. The prevalence of hemorrhoids is found particularly between the age of 45 and 65, both in men and women. However, only a small percentage of the affected population seek any form of medical treatment like medication or surgery and instead opt for relief pills purchased from pharmacies. The growing old-age population is also one of the key contributors to the global demand for  hemorrhoids treatment market . However, lack of awareness and hesitancy towards medical treatment due to the feeling of embarrassment stands

  Market Research Future (MRFR) has projected in its latest report that the global cannula market, valued at USD 113 Mn in 2017, is anticipated to exhibit a CAGR of 6.7% over the forecast period 2018 to 2023. A cannula is a hollow retractable tube which is used for removal or delivery of fluids through insertion into vein, arteries or other body cavities. Increasing healthcare services centers in conjunction with the rising patient population is expected to favor market growth in the years to come. The rising incidences of life-threatening diseases such as cancer, liver cirrhosis, cardiovascular diseases, diabetes, etc. have led to an exponential rise in the demand for medical facilities. The advanced nature of these diseases has led to an increase in demand for long-term or lifetime access to healthcare services. This, in turn, is forecasted to augment the global  cannula market  over the next couple of years. The exponentially rising geriatric population is expected to reflect on the

  A report was recently published by Market Research Future (MRFR) assessing the dynamics in the global facial injectors market over the forecast period of 2018-2023. The facial injectors market is set to march on the growth trajectory at a CAGR of 11.12%, garnering a revenue valuation of USD 14571.47 million by the end of the forecast period. Various attributable factors to the growth of the  facial injectors market  are studied in the MRFR report. Booming of the entertainment industry and increased popularity of celebrity culture is affecting the lifestyle choices of the urban population and elevating bars of beauty standard measurements. Proliferating research and development for advanced aesthetic injectors, along with a growing demand for anti-aging and other beauty treatments in many emerging countries are attributed to the mounting growth of the facial injectors market over the assessment period. Incorporation of advanced technologies in the healthcare sector has contributed hea

  The latest report on the   Healthcare Cold Chain Logistics Market , published by Market Research Future (MRFR), reveals a possibility for the global market to achieve a 7.54% CAGR during the forecast period (2018-2023). It can pick up a valuation of USD 16588.3 million by the end of 2023. Increasing export, advancing biomedical facilities, growing investment in the stem cell research departments and advancements made in personalized drugs sector are factors that can trigger the growth of the Healthcare cold chain logistics Market. All these areas require a controlled atmosphere which is increasing the demand for such extensive services. However, lack of expert technicians to handle such cutting-edge devices can pose challenges for the Healthcare cold chain logistics Market growth during the forecast period.   Leading companies to make a mark in the Healthcare cold chain logistics Market are American Airlines, Inc., AmerisourceBergen Corporation, Marken, DB Schenker, FedEx, KUEHNE + N

  The controlled release drug delivery market is growing rapidly over the past few years. Increasing prevalence of chronic diseases and increasing government regulation to prevent overdose effects act as a significant driving force pushing up the market growth. Furthermore, the growing geriatric and pediatric population is creating huge market demand. Moreover, the advantages that these controlled release drug delivery systems offer accelerate the growth of the market. According to Market Research Future (MRFR), the global  controlled release drug delivery market  is expected to create a valuation of over USD 70.15 BN by 2023, growing at a double-digit CAGR of 14 % during the review period (2018 – 2023). Technological advancements, improved outcomes & patients' experience, beneficial reimbursement policies, and increasing awareness towards healthcare are other key factors impacting the market growth, positively. On the other hand, some limitations associated with the applicatio

  As per Market Research Future (MRFR) analysis, the global mycoplasma testing market is estimated to expand significantly over the forecast period. The global   mycoplasma testing market   held a market value of USD 514 million in 2017 and is anticipated to grow at a CAGR of 11.6% from 2018 to 2023 (forecast period). The term "mycoplasma" refers to a genus of bacteria usually found in cell culture. These bacteria lack a cell wall more correctly known as mollicutes, making them resistant to widely used antibiotics, such as penicillin. Mycoplasma is quickly transmitted by droplets during cell culture and can persist in dry form for months. Contamination of mycoplasma is challenging to see with a microscope and requires complex tests to be identified. Contamination may have a profound impact on experimental work. Depending on the species present, mycoplasma organisms may affect cell growth, metabolism, tumorigenicity, and the response to chemotherapy. Increasing research and de

  The global neuroprosthetics market, as per the reports of Market Research Future (MRFR), is expected to grow by 12.4% during the forecast period (2018-2023). The period would also experience the neuroprosthetics market surpassing USD 10.48 billion valuation. Neuroprosthetics is a blend of neuroscience and biomedical engineering where a series of equipment is used that can be a substitute for a motor, sensory or cognitive modality. Primarily, this type of treatment takes place when injuries or diseases cause damage to any of the neurological system. By replacing damaged senses, these modifications aim at providing better life standard for people with disabilities.  These products are also used to understand animal behavior by monitoring emitted brain signals in laboratories and research centers. MRFR, in their recent report, included detailed segmental analysis for a better understanding of the market. The analysis is based on volume-wise and value-wise reading of the market. Simultan

  The global Spirometry market is witnessing a significant rise in its revenues, mainly due to the rising occurrences of respiratory diseases such as asthma and COPD. Besides, the growing rate of diagnosis processes conducted for the detection of interstitial pulmonary fibrosis fosters the growth of the market. Moreover, the increasing exposure to risk factors and the ever-increasing population is driving a large share of the market. According to Market Research Future (MRFR), the global  Spirometry market  is expected to garner a valuation of USD 1,106.76 MN by 2023, registering 10.03% CAGR over the assessment period (2018-2023). Factors such as the increasing healthcare expenditures and technological advances in respiratory care devices are estimated to support market growth over the forecast period. Spirometry is a medical test to evaluate lung functions vital for detecting asthma, COPD, and other breathing disorders. Spirometry is also performed for therapeutic reasons for asthma,

  The Market Research Reports (MRFR) has revealed that the global digital therapeutics market is estimated to grow at a notable CAGR, holding a substantial market value during the assessment period. The increasing prevalence of chronic diseases is projected to be one of the most significant factors driving the global digital therapeutics market 2020. The growing ailments have created a surmountable pressure on the healthcare sector to develop an efficient method of health analysis and to provide quality analysis assessments, which is anticipated to bring a direct impact on the market. Further, the increasing application of  digital therapeutics market  is estimated to assists the patients with several benefits, which is likely to escalate the global market during the forecast period. Besides, digital therapeutics assist in lessening the cost associated with chronic diseases. In addition, the favorable initiatives taken by the government for healthcare, along with the persistent develop

  Biopreservation is the preservation of biological materials through the use of natural flora and its antibacterial products and forms an integral part in both the food and healthcare industry. The global  biopreservation market  is on an upward growth trajectory and is estimated to strike a CAGR of 11.2% over the forecast period of 2018-2023, predicts Market Research Future (MRFR). Adult mesenchymal stem cells have gained huge momentum as it is a promising source for cell therapies and tissue engineering applications due to which the demand for stem cell preservation has increased drastically. Biopreservation is a crucial aspect of cell and gene-based therapy biopreservation. Growth in number of cryogenic storage facilities is expected to induce high demand within the global biopreservation market. The global biopreservation market is also growing in tandem with recent advances in interrelated, emerging and evolving field of biospecimen procurement, processing, preservation and banki